Dimiter Avtanski: Feinstein Institute for Medical Research, USA
Ramkumar Mohan: University of Michigan Medical School, USA
Submission Status: Open | Submission Deadline: 29 December 2023
BMC Endocrine Disorders is calling for submissions to our Collection on Cellular and Molecular Therapies and Mechanisms of Endocrine Disorders.
Currently, the therapeutic options for patients with endocrine disorders are very limited, ineffective, challenging to implement, and accompanied by adverse side effects. Advancing our understanding of the basic molecular mechanisms responsible for the pathophysiology of endocrine disorders will lead to the generation of better cellular and animal disease models, more efficient drugs, and novel cell- and gene-therapy protocols.